Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

Britain's media regulator launched an investigation into Elon Musk's X on Monday over concerns its Grok AI chatbot was creating sexually intimate deepfake images in violation of its duty to protect ...